Agitated Solutions Enrolls First Patient in Phase 3 'ENHANCE' Trial of Novel Contrast Agent for Cardiac Bubble Studies
First patient has been enrolled at Northwestern University by cardiologist Akhil Narang, M.D. ST. PAUL, MN, UNITED STATES, November 6, 2025 /EINPresswire.com/ -- • Agitated Solutions, Inc.’s ASI-02 is intended to opacify the right heart and to …